Pathophysiology Foundations – Week 1-2 Video Lecture

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/47

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering key terms from a two-hour pathophysiology lecture on course structure, inflammation, burns, arthritis, osteoporosis, aging, and basic infection concepts.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

48 Terms

1
New cards

Pathophysiology

The study of functional changes in cells, tissues, and organs caused by injury, disorder, or disease.

2
New cards

Etiology

The cause or origin of a disease (e.g., autoimmune, genetic, infectious).

3
New cards

Pathogenesis

The sequence of events that leads from the cause of a disease to its clinical manifestations.

4
New cards

Clinical Manifestations

Observable signs and reported symptoms associated with a disease.

5
New cards

Prognosis

A predicted outcome or course of a disease over time.

6
New cards

Incidence

The number of new cases of a disease occurring in a specific time period.

7
New cards

Prevalence

The total number of existing cases of a disease at a particular point in time.

8
New cards

Inflammation

A protective vascular response to tissue injury marked by redness, heat, swelling, pain, and loss of function.

9
New cards

Five Cardinal Signs of Inflammation

Pain, heat (warmth), redness, swelling, and loss of function.

10
New cards

Vasodilation

Widening of blood vessels that increases blood flow to injured tissue during inflammation.

11
New cards

Capillary Permeability

The ability of capillary walls to allow fluids and cells to pass into surrounding tissue; rises during inflammation.

12
New cards

Phagocytes

White blood cells that engulf and destroy pathogens and debris (e.g., neutrophils, macrophages).

13
New cards

Leukocytosis

An elevated white-blood-cell count, often indicating systemic inflammation or infection.

14
New cards

Complement System

A plasma protein cascade that amplifies inflammation and promotes pathogen destruction.

15
New cards

Kinins

Plasma peptides (e.g., bradykinin) that increase pain, vasodilation, and vascular permeability.

16
New cards

Acute Inflammation

Rapid, short-term response to injury aimed at removing the injurious agent and restoring tissue.

17
New cards

Chronic Inflammation

Prolonged inflammatory response lasting weeks to years, often leading to tissue damage and fibrosis.

18
New cards

Exudate

Fluid that leaks out of vessels during inflammation; may be serous, sanguineous, serosanguineous, or purulent.

19
New cards

Serous Exudate

Clear, watery fluid seen in mild inflammation or superficial burns.

20
New cards

Purulent Exudate

Thick, yellow-green drainage rich in pus and microorganisms.

21
New cards

Sanguineous Exudate

Bloody drainage indicating vascular damage.

22
New cards

Serosanguineous Exudate

Thin, pink, watery fluid containing both serum and blood.

23
New cards

Dehiscence

Reopening of a previously closed surgical wound.

24
New cards

Keloid

Excessive scar tissue formation extending beyond the original wound boundaries.

25
New cards

Adhesion

Internal bands of scar tissue that abnormally connect tissues or organs after surgery or inflammation.

26
New cards

Superficial Burn

Burn injury limited to the epidermis; presents with redness, pain, and mild swelling.

27
New cards

Partial-Thickness Burn

Burn involving epidermis and part of the dermis; characterized by blisters and serous exudate.

28
New cards

Full-Thickness Burn

Burn that destroys epidermis, dermis, and often subcutaneous tissue; typically painless with eschar formation.

29
New cards

Eschar

Hard, leathery, dead tissue formed after a full-thickness burn or severe ulcer.

30
New cards

Rule of Nines

Quick method to estimate total body surface area burned by assigning multiples of 9 % to body regions.

31
New cards

Osteoarthritis (OA)

Degenerative joint disease due to wear-and-tear cartilage loss; usually affects individual joints asymmetrically.

32
New cards

Rheumatoid Arthritis (RA)

Systemic autoimmune disease causing chronic, symmetric inflammation of synovial joints.

33
New cards

Synovium

Membrane lining joint capsules that produces lubricating synovial fluid.

34
New cards

Pannus

Inflamed, granulation tissue overgrowth that erodes cartilage and bone in rheumatoid arthritis.

35
New cards

Ankylosis

Abnormal fusion or stiffness of a joint, often resulting from chronic inflammation.

36
New cards

Osteoporosis

Metabolic bone disease marked by decreased bone mass and porous, fragile bones due to remodeling imbalance.

37
New cards

Osteoblast

Bone-forming cell responsible for producing new bone matrix.

38
New cards

Osteoclast

Bone-resorbing cell that breaks down bone tissue.

39
New cards

Kyphosis

Forward curvature of the thoracic spine, commonly seen in advanced osteoporosis.

40
New cards

Sarcopenia

Age-related loss of skeletal muscle mass and strength.

41
New cards

Senescence

The process of biological aging and gradual deterioration of functional characteristics.

42
New cards

Oxidative Stress

Cellular damage caused by free radicals overwhelming the body’s antioxidant defenses.

43
New cards

Free Radicals

Unstable molecules that damage cells by stealing electrons; generated by pollution, smoking, processed foods, etc.

44
New cards

Antioxidants

Substances (e.g., berries, leafy greens) that neutralize free radicals and reduce oxidative stress.

45
New cards

Incubation Period

Time from pathogen entry to appearance of first signs; patient is often contagious without symptoms.

46
New cards

Prodrome

Early, nonspecific symptoms (fatigue, mild discomfort) indicating onset of disease before full illness.

47
New cards

Chain of Infection

Sequence of factors (agent, reservoir, portal of exit, mode of transmission, portal of entry, susceptible host) required for disease spread.

48
New cards

Evidence-Based Practice (EBP)

Clinical decision-making based on best current research evidence, clinical expertise, and patient values.